Recruiting soon

Telehealth and CGM for Diverse Diabetic Patients

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Continues glucose monitoring with remote glucose monitoring for 90 days

Device
Who is being recruted

Diabetes Mellitus+2

+ Endocrine System Diseases

+ Metabolic Diseases

Over 18 Years
+2 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Supportive Care Study

Interventional
Study Start: April 2025
See protocol details

Summary

Principal SponsorWhite Plains Hospital
Study ContactMichelle Elsener, MBA, BSN, RN-BC, CPHQMore contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: April 1, 2025

Actual date on which the first participant was enrolled.

This study is designed to see if using a Continuous Glucose Monitoring (CGM) device, along with a Remote Patient Monitoring (RPM) program, can help people with diabetes manage their blood sugar better and avoid returning to the hospital. It focuses on people whose diabetes is not well controlled and who have recently left the hospital. By utilizing these innovative monitoring tools, the study aims to find out if more consistent and real-time tracking of blood sugar can lead to better health outcomes, like lower Hemoglobin A1c levels, fewer hospital readmissions, and improved overall health. Participants in the study are divided into two groups: one group receives the usual diabetes care, while the other group gets a Dexcom G7 CGM device and support from specially trained nurses. These nurses check the participants' glucose readings every day. The study lasts for 90 days, during which it measures how well the participants' blood sugar levels are controlled and how often they need to go back to the hospital. This approach hopes to provide insights into whether continuous monitoring and remote support can effectively enhance diabetes management.

Official TitleA Multifaceted Telehealth Approach to Enhancing Glycemic Control and Reducing Readmissions in a Diverse Diabetic Population: A Randomized Control Trial
NCT06830135
Principal SponsorWhite Plains Hospital
Study ContactMichelle Elsener, MBA, BSN, RN-BC, CPHQMore contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

208 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Supportive Care Study

These studies explore ways to improve comfort and daily life for people living with a condition. They may focus on easing symptoms, reducing treatment side effects, or supporting overall well-being.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Diabetes MellitusEndocrine System DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesGlucose Metabolism Disorders

Criteria

1 inclusion criteria required to participate
Discharged Home from the WPH Inpatient Setting A1c >= 8.0 within 90 days of discharge >= 18 Years of Age Lives within Westchester County

1 exclusion criteria prevent from participating
18 Years of Age Patient With Documented Cognitive Impairment or Decisional Incapacity Pregnant or Plans to Become Pregnant in 6 Months Discharge Disposition of Short-term or Long-term Care Facility, Assisted Living Facility, Group Home, Against Medical Advice/Eloped, or Home Hospice Patient or Caregiver Unable to Check Glucose at Home Using a Home Glucometer Lives Outside Westchester County

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Continuous glucose monitoring, remote patient monitoring for 90 days

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.
This study has no location dataSave this study to your profile to know when the location data is available.
Recruiting soonNo study centers
Telehealth and CGM for Diverse Diabetic Patients | PatLynk